Xilio Therapeutics (XLO) Other Non-Current Liabilities (2020 - 2026)

Xilio Therapeutics (XLO) posted Other Non-Current Liabilities of $26.3 million for Q1 2026, down 11.16% sequentially from $29.6 million in Q4 2025.

Xilio Therapeutics (XLO) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Xilio Therapeutics has reported Other Non-Current Liabilities for 6 years, with the latest figure at $26.3 million in Q1 2026.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $26.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.3 million (changed N/A YoY) and the FY2025 annual result came in at $29.6 million, changed N/A from the prior year.
Other Non-Current Liabilities fell to $26.3 million in Q1 2026 per XLO's latest filing, from $29.6 million in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $53.9 million in Q3 2025 and troughed at $7000.0 in Q2 2023.
A 4-year average of $14.9 million and a median of $91000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 61.86% in 2022, down 95.8% in 2022.
Over 4 years, Other Non-Current Liabilities stood at $45000.0 in 2022, then sank by 84.44% to $7000.0 in 2023, then jumped by 422185.71% to $29.6 million in 2025, then decreased by 11.16% to $26.3 million in 2026.
According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $26.3 million, $29.6 million, and $53.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Xilio Therapeutics	178.33 Mn	42.29 Mn	-

Download Data